卵巢癌的精准靶向治疗
Precision targeted therapy of ovarian cancer.
作者信息
Sapiezynski Justin, Taratula Oleh, Rodriguez-Rodriguez Lorna, Minko Tamara
机构信息
Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, United States.
Department of Pharmaceutical Sciences, Oregon State University, Portland, OR 97239, United States.
出版信息
J Control Release. 2016 Dec 10;243:250-268. doi: 10.1016/j.jconrel.2016.10.014. Epub 2016 Oct 14.
Abstract
The review is aimed at describing modern approaches to detection as well as precision and personalized treatment of ovarian cancer. Modern methods and future directions of nanotechnology-based targeted and personalized therapy are discussed.
摘要
本综述旨在描述卵巢癌检测的现代方法以及精准和个性化治疗。讨论了基于纳米技术的靶向和个性化治疗的现代方法及未来方向。
相似文献
1
Precision targeted therapy of ovarian cancer.卵巢癌的精准靶向治疗
J Control Release. 2016 Dec 10;243:250-268. doi: 10.1016/j.jconrel.2016.10.014. Epub 2016 Oct 14.
2
Ovarian Cancer Immunotherapy and Personalized Medicine.卵巢癌免疫治疗与个性化医学。
Int J Mol Sci. 2021 Jun 18;22(12):6532. doi: 10.3390/ijms22126532.
3
Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer.新型纳米技术在卵巢癌诊断和治疗中的应用。
Gynecol Oncol. 2011 Mar;120(3):393-403. doi: 10.1016/j.ygyno.2010.11.029. Epub 2010 Dec 18.
4
Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.临床蛋白质组学驱动的精准癌症靶向治疗：当前概述与未来展望
Expert Rev Proteomics. 2016;13(4):367-81. doi: 10.1586/14789450.2016.1159959. Epub 2016 Mar 16.
5
Molecular approaches to personalizing management of ovarian cancer.分子方法在卵巢癌个体化管理中的应用。
Ann Oncol. 2011 Dec;22 Suppl 8(Suppl 8):viii5-viii15. doi: 10.1093/annonc/mdr516.
6
Synthetic Lethality: From Research to Precision Cancer Nanomedicine.合成致死性：从研究到精准癌症纳米医学。
Curr Cancer Drug Targets. 2018;18(4):337-346. doi: 10.2174/1568009617666170630141931.
7
A personalized paradigm in the treatment of platinum-resistant ovarian cancer - A cost utility analysis of genomic-based versus cytotoxic therapy.铂耐药卵巢癌治疗中的个性化模式——基于基因组学疗法与细胞毒性疗法的成本效用分析
Gynecol Oncol. 2016 Jul;142(1):144-149. doi: 10.1016/j.ygyno.2016.04.024. Epub 2016 May 2.
8
What's in a word? The person of personalized (nano)medicine.一个词里有什么？个性化（纳米）医学之人。
Nanomedicine (Lond). 2015;10(20):3167-79. doi: 10.2217/nnm.15.145. Epub 2015 Oct 8.
9
Ovarian cancer national alliance: a report of the 2012 Consensus Conference on Current Challenges in ovarian cancer.卵巢癌全国联盟：2012年卵巢癌当前挑战共识会议报告
Gynecol Oncol. 2013 Jul;130(1):9-11. doi: 10.1016/j.ygyno.2013.04.006.
10
Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.使用基于靶向药物的分子生物标志物对卵巢透明细胞癌进行特征分析：对个性化癌症治疗的意义。
J Ovarian Res. 2017 Feb 10;10(1):9. doi: 10.1186/s13048-017-0304-9.
引用本文的文献
1
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation.FAM64A通过抑制TWIST1的泛素化和降解促进卵巢癌的增殖和转移。
Endocr Relat Cancer. 2025 Jun 16;32(6). doi: 10.1530/ERC-24-0048. Print 2025 Jun 1.
2
Targeting the FSH/FSHR axis in ovarian cancer: advanced treatment using nanotechnology and immunotherapy.靶向卵巢癌中的促卵泡激素/促卵泡激素受体轴：利用纳米技术和免疫疗法的先进治疗方法
Front Endocrinol (Lausanne). 2024 Dec 17;15:1489767. doi: 10.3389/fendo.2024.1489767. eCollection 2024.
3
Beyond 2D cell cultures: how 3D models are changing the study of ovarian cancer and how to make the most of them.超越 2D 细胞培养：3D 模型如何改变卵巢癌的研究以及如何充分利用它们。
PeerJ. 2024 Aug 29;12:e17603. doi: 10.7717/peerj.17603. eCollection 2024.
4
Synergistic antitumor effect of liposomal-based formulations of olaparib and topotecan in primary epithelial ovarian cancer cells.奥拉帕利和拓扑替康脂质体制剂对原发性上皮性卵巢癌细胞的协同抗肿瘤作用。
Cancer Cell Int. 2024 Aug 12;24(1):285. doi: 10.1186/s12935-024-03469-0.
5
Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer.个体化与精准纳米医学治疗卵巢癌。
Small. 2024 Oct;20(41):e2307462. doi: 10.1002/smll.202307462. Epub 2024 Feb 11.
6
Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.通过多组学数据分析对高级别浆液性卵巢癌进行分子簇挖掘有助于精准医疗。
J Cancer Res Clin Oncol. 2023 Sep;149(11):9151-9165. doi: 10.1007/s00432-023-04831-x. Epub 2023 May 13.
7
Different perspectives on translational genomics in personalized medicine.个性化医疗中转化基因组学的不同观点。
J Turk Ger Gynecol Assoc. 2022 Dec 8;23(4):314-321. doi: 10.4274/jtgga.galenos.2022.2021-11-4.
8
Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets.上皮性卵巢癌中的环状RNA：从生物标志物到治疗靶点
Cancers (Basel). 2022 Nov 21;14(22):5711. doi: 10.3390/cancers14225711.
9
Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer.基于纳米技术的核酸疫苗治疗卵巢癌。
Pharm Res. 2023 Jan;40(1):123-144. doi: 10.1007/s11095-022-03434-4. Epub 2022 Nov 14.
10
circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with FUS to stabilize FOXR2.环状ANKRD17（即circ_0007883）通过与FUS相互作用以稳定FOXR2，赋予卵巢癌对紫杉醇的抗性。
Mol Cell Biochem. 2023 Apr;478(4):835-850. doi: 10.1007/s11010-022-04548-4. Epub 2022 Sep 15.
本文引用的文献
1
Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value.用于细胞凋亡分子成像的纳米颗粒设计考虑因素：诊断、预后和治疗价值。
Adv Drug Deliv Rev. 2017 Apr;113:122-140. doi: 10.1016/j.addr.2016.06.016. Epub 2016 Jun 29.
2
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.人类高级别浆液性卵巢癌的综合蛋白质基因组特征分析
Cell. 2016 Jul 28;166(3):755-765. doi: 10.1016/j.cell.2016.05.069. Epub 2016 Jun 29.
3
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal.粘着斑激酶（FAK）在抗血管生成治疗停药后调节血小板外渗和肿瘤生长。
J Clin Invest. 2016 May 2;126(5):1885-96. doi: 10.1172/JCI85086. Epub 2016 Apr 11.
4
Can advanced-stage ovarian cancer be cured?晚期卵巢癌可以治愈吗？
Nat Rev Clin Oncol. 2016 Apr;13(4):255-61. doi: 10.1038/nrclinonc.2015.224. Epub 2016 Jan 20.
5
Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia.急性淋巴细胞白血病患儿中叶酸代谢酶编码基因的功能变异与甲氨蝶呤相关毒性
Eur J Pharmacol. 2015 Dec 15;769:93-9. doi: 10.1016/j.ejphar.2015.10.058. Epub 2015 Nov 1.
6
Single-Cell Analysis in Cancer Genomics.癌症基因组学中的单细胞分析
Trends Genet. 2015 Oct;31(10):576-586. doi: 10.1016/j.tig.2015.07.003.
7
A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.2015年预测性分子病理学及其在靶向癌症治疗中的作用更新：聚焦临床相关性的综述
Cancer Gene Ther. 2015 Sep;22(9):417-30. doi: 10.1038/cgt.2015.39. Epub 2015 Sep 11.
8
Epigenome-based personalized medicine in human cancer.基于表观基因组的人类癌症个性化医疗。
Epigenomics. 2016 Jan;8(1):119-33. doi: 10.2217/epi.15.84. Epub 2015 Sep 7.
9
Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer.使用基于靶向脂质体的化疗药物治疗乳腺癌。
Breast Cancer (Auckl). 2015 Aug 10;9(Suppl 2):1-5. doi: 10.4137/BCBCR.S29421. eCollection 2015.
10
Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments.靶向叶酸受体：个性化癌症治疗的诊断和治疗方法。
Ann Oncol. 2015 Oct;26(10):2034-43. doi: 10.1093/annonc/mdv250. Epub 2015 Jun 10.
Zotero 插件